{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:01:36Z","timestamp":1793070096574,"version":"4.5.0"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1038\/s41582-018-0101-0","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T06:31:02Z","timestamp":1542609062000},"page":"40-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":415,"title":["POLG-related disorders and their neurological manifestations"],"prefix":"10.1038","volume":"15","author":[{"given":"Shamima","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,19]]},"reference":[{"key":"101_CR1","doi-asserted-by":"crossref","first-page":"13534","DOI":"10.1073\/pnas.1109263108","volume":"108","author":"C Kukat","year":"2011","unstructured":"Kukat, C. et al. Super-resolution microscopy reveals that mammalian mitochondrial nucleoids have a uniform size and frequently contain a single copy of mtDNA. Proc. Natl Acad. Sci. USA 108, 13534\u201313539 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"101_CR2","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/sj.emboj.7600257","volume":"23","author":"JA Korhonen","year":"2004","unstructured":"Korhonen, J. A., Pham, X. H., Pellegrini, M. & Falkenberg, M. Reconstitution of a minimal mtDNA replisome in vitro. EMBO J. 23, 2423\u20132429 (2004).","journal-title":"EMBO J."},{"key":"101_CR3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.dnarep.2014.03.010","volume":"19","author":"WC Copeland","year":"2014","unstructured":"Copeland, W. C. & Longley, M. J. Mitochondrial genome maintenance in health and disease. DNA Repair 19, 190\u2013198 (2014).","journal-title":"DNA Repair"},{"key":"101_CR4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0065-3233(04)69005-X","volume":"69","author":"K Bebenek","year":"2004","unstructured":"Bebenek, K. & Kunkel, T. A. Functions of DNA polymerases. Adv. Protein Chem. 69, 137\u2013165 (2004).","journal-title":"Adv. Protein Chem."},{"key":"101_CR5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/geno.1996.0490","volume":"36","author":"PA Ropp","year":"1996","unstructured":"Ropp, P. A. & Copeland, W. C. Cloning and characterization of the human mitochondrial DNA polymerase, DNA polymerase gamma. Genomics 36, 449\u2013458 (1996).","journal-title":"Genomics"},{"key":"101_CR6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1667\/RR0706.1","volume":"166","author":"JB Sweasy","year":"2006","unstructured":"Sweasy, J. B., Lauper, J. M. & Eckert, K. A. DNA polymerases and human diseases. Radiat. Res. 166, 693\u2013714 (2006).","journal-title":"Radiat. Res."},{"key":"101_CR7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1021\/cr040463d","volume":"106","author":"MA Graziewicz","year":"2006","unstructured":"Graziewicz, M. A., Longley, M. J. & Copeland, W. C. DNA polymerase gamma in mitochondrial DNA replication and repair. Chem. Rev. 106, 383\u2013405 (2006).","journal-title":"Chem. Rev."},{"key":"101_CR8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.biochem.72.121801.161455","volume":"73","author":"LS Kaguni","year":"2004","unstructured":"Kaguni, L. S. DNA polymerase gamma, the mitochondrial replicase. Annu. Rev. Biochem. 73, 293\u2013320 (2004).","journal-title":"Annu. Rev. Biochem."},{"key":"101_CR9","doi-asserted-by":"crossref","first-page":"38197","DOI":"10.1074\/jbc.274.53.38197","volume":"274","author":"SE Lim","year":"1999","unstructured":"Lim, S. E., Longley, M. J. & Copeland, W. C. The\u00a0mitochondrial p55 accessory subunit of human DNA polymerase gamma enhances DNA binding, promotes processive DNA synthesis, and confers N-ethylmaleimide resistance. J. Biol. Chem. 274, 38197\u201338203 (1999).","journal-title":"J. Biol. Chem."},{"key":"101_CR10","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1093\/hmg\/ddv240","volume":"24","author":"MJ Young","year":"2015","unstructured":"Young, M. J., Humble, M. M., DeBalsi, K. L., Sun, K. Y. & Copeland, W. C. POLG2 disease variants: analyses reveal a dominant negative heterodimer, altered mitochondrial localization and impaired respiratory capacity. Hum. Mol. Genet. 24, 5184\u20135197 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"101_CR11","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1021\/bi992104w","volume":"39","author":"AA Johnson","year":"2000","unstructured":"Johnson, A. A., Tsai, Y., Graves, S. W. & Johnson, K. A. Human mitochondrial DNA polymerase holoenzyme: reconstitution and characterization. Biochemistry 39, 1702\u20131708 (2000).","journal-title":"Biochemistry"},{"key":"101_CR12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/90034","volume":"28","author":"G Goethem Van","year":"2001","unstructured":"Van Goethem, G., Dermaut, B., Lofgren, A., Martin, J. J. & Van Broeckhoven, C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat. Genet. 28, 211\u2013212 (2001).","journal-title":"Nat. Genet."},{"key":"101_CR13","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1212\/01.WNL.0000140494.58732.83","volume":"63","author":"G Goethem Van","year":"2004","unstructured":"Van Goethem, G. et al. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 63, 1251\u20131257 (2004).","journal-title":"Neurology"},{"key":"101_CR14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0960-8966(02)00216-X","volume":"13","author":"G Goethem Van","year":"2003","unstructured":"Van Goethem, G. et al. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul. Disord. 13, 133\u2013142 (2003).","journal-title":"Neuromuscul. Disord."},{"key":"101_CR15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1086\/444548","volume":"77","author":"AH Hakonen","year":"2005","unstructured":"Hakonen, A. H. et al. Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am. J. Hum. Genet. 77, 430\u2013441 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"101_CR16","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ana.20079","volume":"55","author":"RK Naviaux","year":"2004","unstructured":"Naviaux, R. K. & Nguyen, K. V. POLG mutations associated with Alpers\u2019 syndrome and mitochondrial DNA depletion. Ann. Neurol. 55, 706\u2013712 (2004).","journal-title":"Ann. Neurol."},{"key":"101_CR17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ana.20544","volume":"58","author":"RK Naviaux","year":"2005","unstructured":"Naviaux, R. K. & Nguyen, K. V. POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion. Ann. Neurol. 58, 491 (2005).","journal-title":"Ann. Neurol."},{"key":"101_CR18","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1212\/01.WNL.0000156516.77696.5A","volume":"64","author":"S Winterthun","year":"2005","unstructured":"Winterthun, S. et al. Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology 64, 1204\u20131208 (2005).","journal-title":"Neurology"},{"key":"101_CR19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1445-5994.2012.02847.x","volume":"43","author":"P Woodbridge","year":"2013","unstructured":"Woodbridge, P., Liang, C., Davis, R. L., Vandebona, H. & Sue, C. M. POLG mutations in Australian patients with mitochondrial disease. Intern. Med. J. 43, 150\u2013156 (2013).","journal-title":"Intern. Med. J."},{"key":"101_CR20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1469-8749.2011.04214.x","volume":"54","author":"S Rahman","year":"2012","unstructured":"Rahman, S. Mitochondrial disease and epilepsy. Dev. Med. Child Neurol. 54, 397\u2013406 (2012).","journal-title":"Dev. Med. Child Neurol."},{"key":"101_CR21","volume":"3","author":"E Bugiardini","year":"2017","unstructured":"Bugiardini, E. et al. Clinicopathologic and molecular spectrum of RNASEH1-related mitochondrial disease. Neurol. Genet. 3, e149 (2017).","journal-title":"Neurol. Genet."},{"key":"101_CR22","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1002\/mds.23286","volume":"25","author":"J Schicks","year":"2010","unstructured":"Schicks, J., Synofzik, M., Schulte, C. & Schols, L. POLG, but not PEO1, is a frequent cause of cerebellar ataxia in Central Europe. Mov. Disord. 25, 2678\u20132682 (2010).","journal-title":"Mov. Disord."},{"key":"101_CR23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","volume":"77","author":"GS Gorman","year":"2015","unstructured":"Gorman, G. S. et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann. Neurol. 77, 753\u2013759 (2015).","journal-title":"Ann. Neurol."},{"key":"101_CR24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ddrr.105","volume":"16","author":"RP Saneto","year":"2010","unstructured":"Saneto, R. P. & Naviaux, R. K. Polymerase gamma disease through the ages. Dev. Disabil. Res. Rev. 16, 163\u2013174 (2010).","journal-title":"Dev. Disabil. Res. Rev."},{"key":"101_CR25","doi-asserted-by":"crossref","first-page":"E150","DOI":"10.1002\/humu.20824","volume":"29","author":"LJ Wong","year":"2008","unstructured":"Wong, L. J. et al. Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum.\u00a0Mutat. 29, E150\u2013E172 (2008).","journal-title":"Hum. Mutat."},{"key":"101_CR26","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/gim.2017.35","volume":"19","author":"O Hikmat","year":"2017","unstructured":"Hikmat, O. et al. The clinical spectrum and natural history of early-onset diseases due to DNA polymerase gamma mutations. Genet. Med. 19, 1217\u20131225 (2017).","journal-title":"Genet. Med."},{"key":"101_CR27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/088307389000500402","volume":"5","author":"BN Harding","year":"1990","unstructured":"Harding, B. N. Progressive neuronal degeneration of childhood with liver disease (Alpers\u2013Huttenlocher syndrome): a personal review. J. Child Neurol. 5, 273\u2013287 (1990).","journal-title":"J. Child Neurol."},{"key":"101_CR28","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1528-1167.2008.01877.x","volume":"50","author":"NI Wolf","year":"2009","unstructured":"Wolf, N. I. et al. Status epilepticus in children with Alpers\u2019 disease caused by POLG1 mutations: EEG and MRI features. Epilepsia 50, 1596\u20131607 (2009).","journal-title":"Epilepsia"},{"key":"101_CR29","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1528-1167.2008.01544.x","volume":"49","author":"J Uusimaa","year":"2008","unstructured":"Uusimaa, J. et al. Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus. Epilepsia 49, 1038\u20131045 (2008).","journal-title":"Epilepsia"},{"key":"101_CR30","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1212\/WNL.0b013e3181d90005","volume":"74","author":"NA Visser","year":"2010","unstructured":"Visser, N. A. et al. Juvenile-onset Alpers syndrome: interpreting MRI findings. Neurology 74, 1231\u20131233 (2010).","journal-title":"Neurology"},{"key":"101_CR31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/archneurol.2007.14","volume":"65","author":"E Wiltshire","year":"2008","unstructured":"Wiltshire, E. et al. Juvenile Alpers disease. Arch. Neurol. 65, 121\u2013124 (2008).","journal-title":"Arch. Neurol."},{"key":"101_CR32","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.0b013e31820e7b25","volume":"76","author":"P Isohanni","year":"2011","unstructured":"Isohanni, P. et al. POLG1 manifestations in childhood. Neurology 76, 811\u2013815 (2011).","journal-title":"Neurology"},{"key":"101_CR33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archneurol.2010.36","volume":"67","author":"MO Harris","year":"2010","unstructured":"Harris, M. O., Walsh, L. E., Hattab, E. M. & Golomb, M. R. Is it ADEM, POLG, or both? Arch. Neurol. 67, 493\u2013496 (2010).","journal-title":"Arch. Neurol."},{"key":"101_CR34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B","volume":"45","author":"RK Naviaux","year":"1999","unstructured":"Naviaux, R. K. et al. Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers\u2019 syndrome. Ann. Neurol. 45, 54\u201358 (1999).","journal-title":"Ann. Neurol."},{"key":"101_CR35","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ana.24525","volume":"78","author":"RG Whittaker","year":"2015","unstructured":"Whittaker, R. G. et al. Epilepsy in adults with mitochondrial disease: a cohort study. Ann. Neurol. 78, 949\u2013957 (2015).","journal-title":"Ann. Neurol."},{"key":"101_CR36","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/epi.13508","volume":"57","author":"ME Anagnostou","year":"2016","unstructured":"Anagnostou, M. E., Ng, Y. S., Taylor, R. W. & McFarland, R. Epilepsy due to mutations in the mitochondrial polymerase gamma (POLG) gene: a clinical and molecular genetic review. Epilepsia 57, 1531\u20131545 (2016).","journal-title":"Epilepsia"},{"key":"101_CR37","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1212\/01.WNL.0000098997.23471.65","volume":"61","author":"G Goethem Van","year":"2003","unstructured":"Van Goethem, G. et al. Patient homozygous for a recessive POLG mutation presents with features of MERRF. Neurology 61, 1811\u20131813 (2003).","journal-title":"Neurology"},{"key":"101_CR38","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1212\/01.wnl.0000261929.92478.3e","volume":"68","author":"M Deschauer","year":"2007","unstructured":"Deschauer, M. et al. MELAS associated with mutations in the POLG1 gene. Neurology 68, 1741\u20131742 (2007).","journal-title":"Neurology"},{"key":"101_CR39","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00415-017-8567-z","volume":"264","author":"D Orsucci","year":"2017","unstructured":"Orsucci, D. et al. Revisiting mitochondrial ocular myopathies: a study from the Italian network. J. Neurol. 264, 1777\u20131784 (2017).","journal-title":"J. Neurol."},{"key":"101_CR40","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(04)16983-3","volume":"364","author":"P Luoma","year":"2004","unstructured":"Luoma, P. et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364, 875\u2013882 (2004).","journal-title":"Lancet"},{"key":"101_CR41","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1093\/humrep\/del076","volume":"21","author":"AT Pagnamenta","year":"2006","unstructured":"Pagnamenta, A. T. et al. Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase gamma. Hum. Reprod. 21, 2467\u20132473 (2006).","journal-title":"Hum. Reprod."},{"key":"101_CR42","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/jnnp-2013-306748","volume":"86","author":"F Hanisch","year":"2015","unstructured":"Hanisch, F. et al. SANDO syndrome in a cohort of 107 patients with CPEO and mitochondrial DNA deletions. J. Neurol. Neurosurg. Psychiatry 86, 630\u2013634 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"101_CR43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.nmd.2016.02.008","volume":"26","author":"M Mancuso","year":"2016","unstructured":"Mancuso, M. et al. \u201cMitochondrial neuropathies\u201d: a\u00a0survey from the large cohort of the Italian network. Neuromuscul. Disord. 26, 272\u2013276 (2016).","journal-title":"Neuromuscul. Disord."},{"key":"101_CR44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.mito.2016.07.014","volume":"30","author":"MP Menezes","year":"2016","unstructured":"Menezes, M. P. et al. Neurophysiological profile of peripheral neuropathy associated with childhood mitochondrial disease. Mitochondrion 30, 162\u2013167 (2016).","journal-title":"Mitochondrion"},{"key":"101_CR45","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s10545-017-0084-9","volume":"40","author":"O Hikmat","year":"2017","unstructured":"Hikmat, O. et al. The presence of anaemia negatively influences survival in patients with POLG disease. J.\u00a0Inherit. Metab. Dis. 40, 861\u2013866 (2017).","journal-title":"J. Inherit. Metab. Dis."},{"key":"101_CR46","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1007\/s00415-014-7428-2","volume":"261","author":"P Prasun","year":"2014","unstructured":"Prasun, P. & Koeberl, D. D. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype in a patient with a novel heterozygous POLG mutation. J. Neurol. 261, 1818\u20131819 (2014).","journal-title":"J. Neurol."},{"key":"101_CR47","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s00415-011-6268-6","volume":"259","author":"S Tang","year":"2012","unstructured":"Tang, S., Dimberg, E. L., Milone, M. & Wong, L. J. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations. J.\u00a0Neurol. 259, 862\u2013868 (2012).","journal-title":"J. Neurol."},{"key":"101_CR48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.ejhg.5201002","volume":"11","author":"G Goethem Van","year":"2003","unstructured":"Van Goethem, G. et al. Novel POLG mutations in progressive external ophthalmoplegia mimicking mitochondrial neurogastrointestinal encephalomyopathy. Eur. J. Hum. Genet. 11, 547\u2013549 (2003).","journal-title":"Eur. J. Hum. Genet."},{"key":"101_CR49","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1684\/epd.2012.0543","volume":"14","author":"MH Martikainen","year":"2012","unstructured":"Martikainen, M. H., Paivarinta, M., Jaaskelainen, S. & Majamaa, K. Successful treatment of POLG-related mitochondrial epilepsy with antiepileptic drugs and low glycaemic index diet. Epileptic Disord. 14, 438\u2013441 (2012).","journal-title":"Epileptic Disord."},{"key":"101_CR50","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/jamaneurol.2016.0355","volume":"73","author":"MH Martikainen","year":"2016","unstructured":"Martikainen, M. H. et al. Clinical, genetic, and radiological features of extrapyramidal movement disorders in mitochondrial disease. JAMA Neurol. 73, 668\u2013674 (2016).","journal-title":"JAMA Neurol."},{"key":"101_CR51","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ana.20831","volume":"59","author":"G Davidzon","year":"2006","unstructured":"Davidzon, G. et al. Early-onset familial parkinsonism due to POLG mutations. Ann. Neurol. 59, 859\u2013862 (2006).","journal-title":"Ann. Neurol."},{"key":"101_CR52","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/mds.22178","volume":"23","author":"KK Johansen","year":"2008","unstructured":"Johansen, K. K., Bindoff, L. A., Rydland, J. & Aasly, J. O. Palatal tremor and facial dyskinesia in a\u00a0patient with POLG1 mutation. Mov. Disord. 23, 1624\u20131626 (2008).","journal-title":"Mov. Disord."},{"key":"101_CR53","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s12311-015-0749-6","volume":"15","author":"N Nicastro","year":"2016","unstructured":"Nicastro, N., Ranza, E., Antonarakis, S. E. & Horvath, J. Pure progressive ataxia and palatal tremor (PAPT) associated with a new polymerase gamma (POLG) mutation. Cerebellum 15, 829\u2013831 (2016).","journal-title":"Cerebellum"},{"key":"101_CR54","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/mds.23307","volume":"25","author":"M Synofzik","year":"2010","unstructured":"Synofzik, M. et al. Complex hyperkinetic movement disorders associated with POLG mutations. Mov. Disord. 25, 2472\u20132475 (2010).","journal-title":"Mov. Disord."},{"key":"101_CR55","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/mds.23960","volume":"27","author":"C Hinnell","year":"2012","unstructured":"Hinnell, C. et al. Dystonia in mitochondrial spinocerebellar ataxia and epilepsy syndrome associated with novel recessive POLG mutations. Mov. Disord. 27, 162\u2013163 (2012).","journal-title":"Mov. Disord."},{"key":"101_CR56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jnnp-2012-303232","volume":"84","author":"RD Pitceathly","year":"2013","unstructured":"Pitceathly, R. D. et al. Distal myopathy with cachexia: an unrecognised phenotype caused by dominantly-inherited mitochondrial polymerase gamma mutations. J. Neurol. Neurosurg. Psychiatry 84, 107\u2013110 (2013).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"101_CR57","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/humrep\/des130","volume":"27","author":"AJ Duncan","year":"2012","unstructured":"Duncan, A. J., Knight, J. A., Costello, H., Conway, G. S. & Rahman, S. POLG mutations and age at menopause. Hum. Reprod. 27, 2243\u20132244 (2012).","journal-title":"Hum. Reprod."},{"key":"101_CR58","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1212\/01.wnl.0000345002.47396.e1","volume":"72","author":"C Giordano","year":"2009","unstructured":"Giordano, C. et al. Fatal congenital myopathy and gastrointestinal pseudo-obstruction due to POLG1 mutations. Neurology 72, 1103\u20131105 (2009).","journal-title":"Neurology"},{"key":"101_CR59","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nrd1201","volume":"2","author":"W Lewis","year":"2003","unstructured":"Lewis, W., Day, B. J. & Copeland, W. C. Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat. Rev. Drug Discov. 2, 812\u2013822 (2003).","journal-title":"Nat. Rev. Drug Discov."},{"key":"101_CR60","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fmolb.2017.00074","volume":"4","author":"MJ Young","year":"2017","unstructured":"Young, M. J. Off-target effects of drugs that disrupt human mitochondrial dna maintenance. Front. Mol. Biosci. 4, 74 (2017).","journal-title":"Front. Mol. Biosci."},{"key":"101_CR61","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM199004193221602","volume":"322","author":"MC Dalakas","year":"1990","unstructured":"Dalakas, M. C. et al. Mitochondrial myopathy caused by long-term zidovudine therapy. N. Engl. J. Med. 322, 1098\u20131105 (1990).","journal-title":"N. Engl. J. Med."},{"key":"101_CR62","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0140-6736(91)91294-5","volume":"337","author":"E Arnaudo","year":"1991","unstructured":"Arnaudo, E. et al. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 337, 508\u2013510 (1991).","journal-title":"Lancet"},{"key":"101_CR63","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1567-7249(02)00003-X","volume":"1","author":"T Dagan","year":"2002","unstructured":"Dagan, T., Sable, C., Bray, J. & Gerschenson, M. Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence? Mitochondrion 1, 397\u2013412 (2002).","journal-title":"Mitochondrion"},{"key":"101_CR64","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/labinvest.3780288","volume":"81","author":"W Lewis","year":"2001","unstructured":"Lewis, W., Copeland, W. C. & Day, B. Mitochondrial DNA depletion, oxidative stress, and mutation: mechanisms of nucleoside reverse transcriptase inhibitor toxicity. Lab. Invest. 81, 777\u2013790 (2001).","journal-title":"Lab. Invest."},{"key":"101_CR65","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/brain\/awl097","volume":"129","author":"C Tzoulis","year":"2006","unstructured":"Tzoulis, C. et al. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a\u00a0study of 26 cases. Brain 129, 1685\u20131692 (2006).","journal-title":"Brain"},{"key":"101_CR66","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2174\/138161211796904795","volume":"17","author":"S Nadanaciva","year":"2011","unstructured":"Nadanaciva, S. & Will, Y. New insights in drug-induced mitochondrial toxicity. Curr. Pharm. Des. 17, 2100\u20132112 (2011).","journal-title":"Curr. Pharm. Des."},{"key":"101_CR67","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1093\/brain\/aws298","volume":"135","author":"VC Neeve","year":"2012","unstructured":"Neeve, V. C. et al. What is influencing the phenotype of the common homozygous polymerase-gamma mutation p.Ala467Thr? Brain 135, 3614\u20133626 (2012).","journal-title":"Brain"},{"key":"101_CR68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145500","volume":"11","author":"S Rajakulendran","year":"2016","unstructured":"Rajakulendran, S. et al. A clinical, neuropathological and genetic study of homozygous A467T POLG-related mitochondrial disease. PLOS ONE 11, e0145500 (2016).","journal-title":"PLOS ONE"},{"key":"101_CR69","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2009.07.050","volume":"139","author":"YS Lee","year":"2009","unstructured":"Lee, Y. S., Kennedy, W. D. & Yin, Y. W. Structural insight into processive human mitochondrial DNA synthesis and disease-related polymerase mutations. Cell 139, 312\u2013324 (2009).","journal-title":"Cell"},{"key":"101_CR70","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.15252\/embj.201591520","volume":"34","author":"MR Szymanski","year":"2015","unstructured":"Szymanski, M. R. et al. Structural basis for processivity and antiviral drug toxicity in human mitochondrial DNA replicase. EMBO J. 34, 1959\u20131970 (2015).","journal-title":"EMBO J."},{"key":"101_CR71","doi-asserted-by":"crossref","first-page":"9072","DOI":"10.1093\/nar\/gkr618","volume":"39","author":"L Euro","year":"2011","unstructured":"Euro, L., Farnum, G. A., Palin, E., Suomalainen, A. & Kaguni, L. S. Clustering of Alpers disease mutations and catalytic defects in biochemical variants reveal new features of molecular mechanism of the human mitochondrial replicase, Pol gamma. Nucleic Acids Res. 39, 9072\u20139084 (2011).","journal-title":"Nucleic Acids Res."},{"key":"101_CR72","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bbacli.2017.04.001","volume":"7","author":"A Nurminen","year":"2017","unstructured":"Nurminen, A., Farnum, G. A. & Kaguni, L. S. Pathogenicity in POLG syndromes: DNA polymerase gamma pathogenicity prediction server and database. BBA Clin. 7, 147\u2013156 (2017).","journal-title":"BBA Clin."},{"key":"101_CR73","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.nmd.2015.01.004","volume":"25","author":"C Scuderi","year":"2015","unstructured":"Scuderi, C. et al. The in cis T251I and P587L POLG1 base changes: description of a new family and literature review. Neuromuscul. Disord. 25, 333\u2013339 (2015).","journal-title":"Neuromuscul. Disord."},{"key":"101_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kft102","volume":"134","author":"JN Meyer","year":"2013","unstructured":"Meyer, J. N. et al. Mitochondria as a target of environmental toxicants. Toxicol. Sci. 134, 1\u201317 (2013).","journal-title":"Toxicol. Sci."},{"key":"101_CR75","unstructured":"Cohen, B. H., Chinnery, P. F. & Copeland, W. C. POLG-related disorders. GeneReviews https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK26471 (updated 1 Mar 2018)."},{"key":"101_CR76","first-page":"1704","volume":"9","author":"N Gattermann","year":"1995","unstructured":"Gattermann, N., Berneburg, M., Heinisch, J., Aul, C. & Schneider, W. Detection of the ageing-associated 5-Kb common deletion of mitochondrial DNA in blood and bone marrow of hematologically normal adults. Absence of the deletion in clonal bone marrow disorders. Leukemia 9, 1704\u20131710 (1995).","journal-title":"Leukemia"},{"key":"101_CR77","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.286.5440.774","volume":"286","author":"Y Michikawa","year":"1999","unstructured":"Michikawa, Y., Mazzucchelli, F., Bresolin, N., Scarlato, G. & Attardi, G. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 286, 774\u2013779 (1999).","journal-title":"Science"},{"key":"101_CR78","doi-asserted-by":"crossref","first-page":"38555","DOI":"10.1074\/jbc.M105230200","volume":"276","author":"MJ Longley","year":"2001","unstructured":"Longley, M. J., Nguyen, D., Kunkel, T. A. & Copeland, W. C. The fidelity of human DNA polymerase gamma with and without exonucleolytic proofreading and the p55 accessory subunit. J. Biol. Chem. 276, 38555\u201338562 (2001).","journal-title":"J. Biol. Chem."},{"key":"101_CR79","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1021\/bi980772w","volume":"37","author":"MJ Longley","year":"1998","unstructured":"Longley, M. J., Ropp, P. A., Lim, S. E. & Copeland, W. C. Characterization of the native and recombinant catalytic subunit of human DNA polymerase gamma: identification of residues critical for exonuclease activity and dideoxynucleotide sensitivity. Biochemistry 37, 10529\u201310539 (1998).","journal-title":"Biochemistry"},{"key":"101_CR80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mrfmmm.2005.12.012","volume":"599","author":"W Zheng","year":"2006","unstructured":"Zheng, W., Khrapko, K., Coller, H. A., Thilly, W. G. & Copeland, W. C. Origins of human mitochondrial point mutations as DNA polymerase gamma-mediated errors. Mutat. Res. 599, 11\u201320 (2006).","journal-title":"Mutat. Res."},{"key":"101_CR81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003794","volume":"9","author":"SR Kennedy","year":"2013","unstructured":"Kennedy, S. R., Salk, J. J., Schmitt, M. W. & Loeb, L. A. Ultra-sensitive sequencing reveals an age-related increase in somatic mitochondrial mutations that are inconsistent with oxidative damage. PLOS Genet. 9, e1003794 (2013).","journal-title":"PLOS Genet."},{"key":"101_CR82","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1073\/pnas.89.16.7370","volume":"89","author":"GA Cortopassi","year":"1992","unstructured":"Cortopassi, G. A., Shibata, D., Soong, N. W. & Arnheim, N. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc. Natl Acad. Sci. USA 89, 7370\u20137374 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"101_CR83","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1093\/nar\/18.23.6927","volume":"18","author":"GA Cortopassi","year":"1990","unstructured":"Cortopassi, G. A. & Arnheim, N. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res. 18, 6927\u20136933 (1990).","journal-title":"Nucleic Acids Res."},{"key":"101_CR84","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.ge.29.120195.001055","volume":"29","author":"NG Larsson","year":"1995","unstructured":"Larsson, N. G. & Clayton, D. A. Molecular genetic aspects of human mitochondrial disorders. Annu. Rev. Genet. 29, 151\u2013178 (1995).","journal-title":"Annu. Rev. Genet."},{"key":"101_CR85","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature02517","volume":"429","author":"A Trifunovic","year":"2004","unstructured":"Trifunovic, A. et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429, 417\u2013423 (2004).","journal-title":"Nature"},{"key":"101_CR86","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1112125","volume":"309","author":"GC Kujoth","year":"2005","unstructured":"Kujoth, G. C. et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481\u2013484 (2005).","journal-title":"Science"},{"key":"101_CR87","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ng1988","volume":"39","author":"M Vermulst","year":"2007","unstructured":"Vermulst, M. et al. Mitochondrial point mutations do not limit the natural lifespan of mice. Nat. Genet. 39, 540\u2013543 (2007).","journal-title":"Nat. Genet."},{"key":"101_CR88","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ng.95","volume":"40","author":"M Vermulst","year":"2008","unstructured":"Vermulst, M. et al. DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice. Nat. Genet. 40, 392\u2013394 (2008).","journal-title":"Nat. Genet."},{"key":"101_CR89","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/brain\/awn007","volume":"131","author":"BA Engelsen","year":"2008","unstructured":"Engelsen, B. A. et al. POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. Brain 131, 818\u2013828 (2008).","journal-title":"Brain"},{"key":"101_CR90","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mito.2016.03.003","volume":"28","author":"C Tzoulis","year":"2016","unstructured":"Tzoulis, C., Schwarzlmuller, T., Biermann, M., Haugarvoll, K. & Bindoff, L. A. Mitochondrial DNA homeostasis is essential for nigrostriatal integrity. Mitochondrion 28, 33\u201337 (2016).","journal-title":"Mitochondrion"},{"key":"101_CR91","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1093\/brain\/awt103","volume":"136","author":"C Tzoulis","year":"2013","unstructured":"Tzoulis, C. et al. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations. Brain 136, 2393\u20132404 (2013).","journal-title":"Brain"},{"key":"101_CR92","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S1474-4422(11)70155-7","volume":"10","author":"A Suomalainen","year":"2011","unstructured":"Suomalainen, A. et al. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol. 10, 806\u2013818 (2011).","journal-title":"Lancet Neurol."},{"key":"101_CR93","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ana.24506","volume":"78","author":"S Yatsuga","year":"2015","unstructured":"Yatsuga, S. et al. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders. Ann. Neurol. 78, 814\u2013823 (2015).","journal-title":"Ann. Neurol."},{"key":"101_CR94","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ymgme.2009.08.005","volume":"99","author":"O Hasselmann","year":"2010","unstructured":"Hasselmann, O. et al. Cerebral folate deficiency and CNS inflammatory markers in Alpers disease. Mol. Genet. Metab. 99, 58\u201361 (2010).","journal-title":"Mol. Genet. Metab."},{"key":"101_CR95","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archneurol.2010.219","volume":"67","author":"A Echaniz-Laguna","year":"2010","unstructured":"Echaniz-Laguna, A. et al. POLG1 variations presenting as multiple sclerosis. Arch. Neurol. 67, 1140\u20131143 (2010).","journal-title":"Arch. Neurol."},{"key":"101_CR96","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/MPG.0000000000001345","volume":"63","author":"P McKiernan","year":"2016","unstructured":"McKiernan, P. et al. Incidence of primary mitochondrial disease in children younger than 2 years presenting with acute liver failure. J. Pediatr. Gastroenterol. Nutr. 63, 592\u2013597 (2016).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"101_CR97","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jns.2011.11.028","volume":"315","author":"EJ Palin","year":"2012","unstructured":"Palin, E. J., Hakonen, A. H., Korpela, M., Paetau, A. & Suomalainen, A. Mitochondrial recessive ataxia syndrome mimicking dominant spinocerebellar ataxia. J. Neurol. Sci. 315, 160\u2013163 (2012).","journal-title":"J. Neurol. Sci."},{"key":"101_CR98","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/nan.12429","volume":"44","author":"D Kirschenbaum","year":"2018","unstructured":"Kirschenbaum, D., Hedberg-Oldfors, C., Oldfors, A., Scherer, E. & Budka, H. Distinctive cerebral neuropathology in an adult case of sensory ataxic neuropathy with dysarthria and ophthalmoplegia (SANDO) syndrome. Neuropathol. Appl. Neurobiol. 44, 639\u2013642 (2018).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"101_CR99","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/sj.ejhg.5201831","volume":"15","author":"AH Hakonen","year":"2007","unstructured":"Hakonen, A. H. et al. Abundance of the POLG disease mutations in Europe, Australia, New Zealand, and the United States explained by single ancient European founders. Eur. J. Hum. Genet. 15, 779\u2013783 (2007).","journal-title":"Eur. J. Hum. Genet."},{"key":"101_CR100","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15824","volume":"8","author":"LS Kremer","year":"2017","unstructured":"Kremer, L. S. et al. Genetic diagnosis of Mendelian disorders via RNA sequencing. Nat. Commun. 8, 15824 (2017).","journal-title":"Nat. Commun."},{"key":"101_CR101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.15252\/emmm.201707993","volume":"10","author":"J Nikkanen","year":"2018","unstructured":"Nikkanen, J. et al. A complex genomic locus drives mtDNA replicase POLG expression to its disease-related nervous system regions. EMBO Mol. Med. 10, 13\u201321 (2018).","journal-title":"EMBO Mol. Med."},{"key":"101_CR102","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/epi.12115","volume":"54","author":"J Uusimaa","year":"2013","unstructured":"Uusimaa, J. et al. Prospective study of POLG mutations presenting in children with intractable epilepsy: prevalence and clinical features. Epilepsia 54, 1002\u20131011 (2013).","journal-title":"Epilepsia"},{"key":"101_CR103","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/brain\/awh410","volume":"128","author":"G Ferrari","year":"2005","unstructured":"Ferrari, G. et al. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. Brain 128, 723\u2013731 (2005).","journal-title":"Brain"},{"key":"101_CR104","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00431-006-0234-9","volume":"166","author":"MC Vries de","year":"2007","unstructured":"de Vries, M. C. et al. Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations. Eur. J.\u00a0Pediatr. 166, 229\u2013234 (2007).","journal-title":"Eur. J. Pediatr."},{"key":"101_CR105","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/brain\/awl088","volume":"129","author":"R Horvath","year":"2006","unstructured":"Horvath, R. et al. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 129, 1674\u20131684 (2006).","journal-title":"Brain"},{"key":"101_CR106","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jhep.2005.12.026","volume":"45","author":"KV Nguyen","year":"2006","unstructured":"Nguyen, K. V., Sharief, F. S., Chan, S. S., Copeland, W. C. & Naviaux, R. K. Molecular diagnosis of Alpers syndrome. J. Hepatol. 45, 108\u2013116 (2006).","journal-title":"J. Hepatol."},{"key":"101_CR107","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/hmg\/ddi196","volume":"14","author":"PT Luoma","year":"2005","unstructured":"Luoma, P. T. et al. Functional defects due to spacer-region mutations of human mitochondrial DNA polymerase in a family with an ataxia-myopathy syndrome. Hum. Mol. Genet. 14, 1907\u20131920 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"101_CR108","doi-asserted-by":"crossref","first-page":"31341","DOI":"10.1074\/jbc.M506762200","volume":"280","author":"SS Chan","year":"2005","unstructured":"Chan, S. S., Longley, M. J. & Copeland, W. C. The common A467T mutation in the human mitochondrial DNA polymerase (POLG) compromises catalytic efficiency and interaction with the accessory subunit. J. Biol. Chem. 280, 31341\u201331346 (2005).","journal-title":"J. Biol. Chem."},{"key":"101_CR109","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1093\/hmg\/ddl424","volume":"15","author":"SSL Chan","year":"2006","unstructured":"Chan, S. S. L., Longley, M. J. & Copeland, W. C. Modulation of the W748S mutation in DNA polymerase gamma by the E1143G polymorphismin mitochondrial disorders. Hum. Mol. Genet. 15, 3473\u20133483 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"101_CR110","doi-asserted-by":"crossref","first-page":"19501","DOI":"10.1074\/jbc.M109.011940","volume":"284","author":"R Kasiviswanathan","year":"2009","unstructured":"Kasiviswanathan, R., Longley, M. J., Chan, S. S. & Copeland, W. C. Disease mutations in the human mitochondrial DNA polymerase thumb subdomain impart severe defects in mitochondrial DNA replication. J. Biol. Chem. 284, 19501\u201319510 (2009).","journal-title":"J. Biol. Chem."},{"key":"101_CR111","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1074\/jbc.M116.773341","volume":"292","author":"KL DeBalsi","year":"2017","unstructured":"DeBalsi, K. L., Longley, M. J., Hoff, K. E. & Copeland, W. C. Synergistic effects of the in cis T251I and P587L mitochondrial dna polymerase gamma disease mutations. J. Biol. Chem. 292, 4198\u20134209 (2017).","journal-title":"J. Biol. Chem."},{"key":"101_CR112","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nsmb805","volume":"11","author":"MA Graziewicz","year":"2004","unstructured":"Graziewicz, M. A., Longley, M. J., Bienstock, R. J., Zeviani, M. & Copeland, W. C. Structure\u2013function defects of human mitochondrial DNA polymerase in\u00a0autosomal dominant progressive external ophthalmoplegia. Nat. Struct. Mol. Biol. 11, 770\u2013776 (2004).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"101_CR113","doi-asserted-by":"crossref","first-page":"15225","DOI":"10.1074\/jbc.C200100200","volume":"277","author":"MV Ponamarev","year":"2002","unstructured":"Ponamarev, M. V., Longley, M. J., Nguyen, D., Kunkel, T. A. & Copeland, W. C. Active site mutation in DNA polymerase gamma associated with progressive external ophthalmoplegia causes error-prone DNA synthesis. J. Biol. Chem. 277, 15225\u201315228 (2002).","journal-title":"J. Biol. Chem."},{"key":"101_CR114","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10545-017-0027-5","volume":"40","author":"C Viscomi","year":"2017","unstructured":"Viscomi, C. & Zeviani, M. MtDNA-maintenance defects: syndromes and genes. J. Inherit. Metab. Dis. 40, 587\u2013599 (2017).","journal-title":"J. Inherit. Metab. Dis."},{"key":"101_CR115","first-page":"5","volume":"48","author":"A Baalen van","year":"2017","unstructured":"van Baalen, A., Vezzani, A., Hausler, M. & Kluger, G. Febrile infection-related epilepsy syndrome: clinical review and hypotheses of epileptogenesis. Neuropediatrics 48, 5\u201318 (2017).","journal-title":"Neuropediatrics"},{"key":"101_CR116","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10545-013-9614-2","volume":"36","author":"S Rahman","year":"2013","unstructured":"Rahman, S. Gastrointestinal and hepatic manifestations of mitochondrial disorders. J. Inherit. Metab. Dis. 36, 659\u2013673 (2013).","journal-title":"J. Inherit. Metab. Dis."},{"key":"101_CR117","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10545-015-9896-7","volume":"39","author":"C Staufner","year":"2016","unstructured":"Staufner, C. et al. Recurrent acute liver failure due to NBAS deficiency: phenotypic spectrum, disease mechanisms, and therapeutic concepts. J. Inherit. Metab. Dis. 39, 3\u201316 (2016).","journal-title":"J. Inherit. Metab. Dis."},{"key":"101_CR118","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1528-1167.2012.03618.x","volume":"53","author":"LA Bindoff","year":"2012","unstructured":"Bindoff, L. A. & Engelsen, B. A. Mitochondrial diseases and epilepsy. Epilepsia 53 (Suppl. 4), 92\u201397 (2012).","journal-title":"Epilepsia"},{"key":"101_CR119","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/adc.2007.122911","volume":"93","author":"R McFarland","year":"2008","unstructured":"McFarland, R. et al. Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1). Arch. Dis. Child. 93, 151\u2013153 (2008).","journal-title":"Arch. Dis. Child."},{"key":"101_CR120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.seizure.2010.01.002","volume":"19","author":"RP Saneto","year":"2010","unstructured":"Saneto, R. P. et al. POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders. Seizure 19, 140\u2013146 (2010).","journal-title":"Seizure"},{"key":"101_CR121","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.eplepsyres.2008.08.005","volume":"82","author":"H Pruss","year":"2008","unstructured":"Pruss, H. & Holtkamp, M. Ketamine successfully terminates malignant status epilepticus. Epilepsy Res. 82, 219\u2013222 (2008).","journal-title":"Epilepsy Res."},{"key":"101_CR122","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00415-010-5721-2","volume":"258","author":"NA Visser","year":"2011","unstructured":"Visser, N. A. et al. Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations. J. Neurol. 258, 218\u2013222 (2011).","journal-title":"J. Neurol."},{"key":"101_CR123","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1212\/WNL.0b013e31820a0d39","volume":"76","author":"R Dhamija","year":"2011","unstructured":"Dhamija, R., Moseley, B. D. & Wirrell, E. C. Clinical reasoning: a 10-month-old boy with myoclonic status epilepticus. Neurology 76, e22\u2013e25 (2011).","journal-title":"Neurology"},{"key":"101_CR124","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00381-011-1495-9","volume":"27","author":"S Lupashko","year":"2011","unstructured":"Lupashko, S., Malik, S., Donahue, D., Hernandez, A. & Perry, M. S. Palliative functional hemispherectomy for treatment of refractory status epilepticus associated with Alpers\u2019 disease. Childs Nerv. Syst. 27, 1321\u20131323 (2011).","journal-title":"Childs Nerv. Syst."},{"key":"101_CR125","first-page":"CD004426","volume":"4","author":"G Pfeffer","year":"2012","unstructured":"Pfeffer, G., Majamaa, K., Turnbull, D. M., Thorburn, D. & Chinnery, P. F. Treatment for mitochondrial disorders. Cochrane Database Syst. Rev. 4, CD004426 (2012).","journal-title":"Cochrane Database Syst. Rev."},{"key":"101_CR126","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/106002809202600104","volume":"26","author":"EA Bell","year":"1992","unstructured":"Bell, E. A. et al. Treatment of valproic acid-associated hepatic failure with orthotopic liver transplantation. Ann. Pharmacother. 26, 18\u201321 (1992).","journal-title":"Ann. Pharmacother."},{"key":"101_CR127","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/lt.23965","volume":"20","author":"J Hynynen","year":"2014","unstructured":"Hynynen, J. et al. Acute liver failure after valproate exposure in patients with POLG1 mutations and the prognosis after liver transplantation. Liver Transpl. 20, 1402\u20131412 (2014).","journal-title":"Liver Transpl."},{"key":"101_CR128","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0041-1345(99)00936-7","volume":"32","author":"MA Thomson","year":"2000","unstructured":"Thomson, M. A., Lynch, S., Strong, R., Shepherd, R. W. & Marsh, W. Orthotopic liver transplantation with poor neurologic outcome in valproate-associated liver failure: a need for critical risk-benefit appraisal in the use of valproate. Transplant. Proc. 32, 200\u2013203 (2000).","journal-title":"Transplant. Proc."},{"key":"101_CR129","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/lt.23988","volume":"20","author":"P McKiernan","year":"2014","unstructured":"McKiernan, P. Acute liver failure after valproate exposure: liver transplantation may be indicated beyond childhood. Liver Transpl. 20, 1287\u20131289 (2014).","journal-title":"Liver Transpl."},{"key":"101_CR130","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jpeds.2010.10.033","volume":"158","author":"AL Mindikoglu","year":"2011","unstructured":"Mindikoglu, A. L. et al. Valproic acid-associated acute liver failure in children: case report and analysis of liver transplantation outcomes in the United States. J.\u00a0Pediatr. 158, 802\u2013807 (2011).","journal-title":"J. Pediatr."},{"key":"101_CR131","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.20240","volume":"56","author":"S Santra","year":"2004","unstructured":"Santra, S., Gilkerson, R. W., Davidson, M. & Schon, E. A. Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells. Ann. Neurol. 56, 662\u2013669 (2004).","journal-title":"Ann. Neurol."},{"key":"101_CR132","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/hmg\/ddq076","volume":"19","author":"S Ahola-Erkkila","year":"2010","unstructured":"Ahola-Erkkila, S. et al. Ketogenic diet slows down mitochondrial myopathy progression in mice. Hum. Mol. Genet. 19, 1974\u20131984 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"101_CR133","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0031-1274035","volume":"42","author":"J Spiegler","year":"2011","unstructured":"Spiegler, J., Stefanova, I., Hellenbroich, Y. & Sperner, J. Bowel obstruction in patients with Alpers\u2013Huttenlocher syndrome. Neuropediatrics 42, 194\u2013196 (2011).","journal-title":"Neuropediatrics"},{"key":"101_CR134","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/0883073811423973","volume":"27","author":"A Khan","year":"2012","unstructured":"Khan, A. et al. Alpers syndrome: the natural history of a case highlighting neuroimaging, neuropathology, and fat metabolism. J. Child Neurol. 27, 636\u2013640 (2012).","journal-title":"J. Child Neurol."},{"key":"101_CR135","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/jnc.12646","volume":"129","author":"SD Hughes","year":"2014","unstructured":"Hughes, S. D. et al. The ketogenic diet component decanoic acid increases mitochondrial citrate synthase and complex I activity in neuronal cells. J. Neurochem. 129, 426\u2013433 (2014).","journal-title":"J. Neurochem."},{"key":"101_CR136","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/brain\/awv325","volume":"139","author":"P Chang","year":"2016","unstructured":"Chang, P. et al. Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain 139, 431\u2013443 (2016).","journal-title":"Brain"},{"key":"101_CR137","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10545-016-9930-4","volume":"39","author":"M Kanabus","year":"2016","unstructured":"Kanabus, M. et al. The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome. J. Inherit. Metab. Dis. 39, 415\u2013426 (2016).","journal-title":"J. Inherit. Metab. Dis."},{"key":"101_CR138","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/hmg\/ddv509","volume":"25","author":"L Pitayu","year":"2016","unstructured":"Pitayu, L. et al. Combined use of Saccharomyces cerevisiae. Caenorhabditis elegans and patient fibroblasts leads to the identification of clofilium tosylate as a potential therapeutic chemical against POLG-related diseases. Hum. Mol. Genet. 25, 715\u2013727 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"101_CR139","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/hmg\/ddg192","volume":"12","author":"JW Taanman","year":"2003","unstructured":"Taanman, J. W., Muddle, J. R. & Muntau, A. C. Mitochondrial DNA depletion can be prevented by dGMP and dAMP supplementation in a resting culture of deoxyguanosine kinase-deficient fibroblasts. Hum. Mol. Genet. 12, 1839\u20131845 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"101_CR140","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ana.24922","volume":"81","author":"C Lopez-Gomez","year":"2017","unstructured":"Lopez-Gomez, C. et al. Deoxycytidine and deoxythymidine treatment for thymidine kinase 2 deficiency. Ann. Neurol. 81, 641\u2013652 (2017).","journal-title":"Ann. Neurol."},{"key":"101_CR141","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/hmg\/ddp074","volume":"18","author":"S Bulst","year":"2009","unstructured":"Bulst, S. et al. In vitro supplementation with dAMP\/dGMP leads to partial restoration of mtDNA levels in mitochondrial depletion syndromes. Hum. Mol. Genet. 18, 1590\u20131599 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"101_CR142","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/emmm.201201433","volume":"4","author":"I Meo Di","year":"2012","unstructured":"Di Meo, I. et al. Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy. EMBO Mol. Med. 4, 1008\u20131014 (2012).","journal-title":"EMBO Mol. Med."},{"key":"101_CR143","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/gt.2011.24","volume":"18","author":"J Torres-Torronteras","year":"2011","unstructured":"Torres-Torronteras, J. et al. Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE. Gene Ther. 18, 795\u2013806 (2011).","journal-title":"Gene Ther."},{"key":"101_CR144","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1086\/504303","volume":"78","author":"MJ Longley","year":"2006","unstructured":"Longley, M. J. et al. Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am. J. Hum. Genet. 78, 1026\u20131034 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"101_CR145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/90058","volume":"28","author":"JN Spelbrink","year":"2001","unstructured":"Spelbrink, J. N. et al. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat. Genet. 28, 223\u2013231 (2001).","journal-title":"Nat. Genet."},{"key":"101_CR146","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ajhg.2015.05.013","volume":"97","author":"A Reyes","year":"2015","unstructured":"Reyes, A. et al. RNASEH1 mutations impair mtDNA replication and cause adult-onset mitochondrial encephalomyopathy. Am. J. Hum. Genet. 97, 186\u2013193 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"101_CR147","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ymgme.2016.07.001","volume":"119","author":"AR Stiles","year":"2016","unstructured":"Stiles, A. R. et al. Mutations in TFAM, encoding mitochondrial transcription factor A, cause neonatal liver failure associated with mtDNA depletion. Mol.\u00a0Genet. Metab. 119, 91\u201399 (2016).","journal-title":"Mol. Genet. Metab."},{"key":"101_CR148","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molcel.2017.11.033","volume":"69","author":"TJ Nicholls","year":"2018","unstructured":"Nicholls, T. J. et al. Topoisomerase 3alpha is required for decatenation and segregation of human mtDNA. Mol. Cell 69, 9\u201323 (2018).","journal-title":"Mol. Cell"},{"key":"101_CR149","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ajhg.2012.12.014","volume":"92","author":"D Ronchi","year":"2013","unstructured":"Ronchi, D. et al. Mutations in DNA2 link progressive myopathy to mitochondrial DNA instability. Am. J. Hum. Genet. 92, 293\u2013300 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"101_CR150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ng.2501","volume":"45","author":"C Kornblum","year":"2013","unstructured":"Kornblum, C. et al. Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease. Nat. Genet. 45, 214\u2013219 (2013).","journal-title":"Nat. Genet."},{"key":"101_CR151","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1126\/science.289.5480.782","volume":"289","author":"J Kaukonen","year":"2000","unstructured":"Kaukonen, J. et al. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289, 782\u2013785 (2000).","journal-title":"Science"},{"key":"101_CR152","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.283.5402.689","volume":"283","author":"I Nishino","year":"1999","unstructured":"Nishino, I., Spinazzola, A. & Hirano, M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283, 689\u2013692 (1999).","journal-title":"Science"},{"key":"101_CR153","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/ng751","volume":"29","author":"A Saada","year":"2001","unstructured":"Saada, A. et al. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat.\u00a0Genet. 29, 342\u2013344 (2001).","journal-title":"Nat. Genet."},{"key":"101_CR154","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng746","volume":"29","author":"H Mandel","year":"2001","unstructured":"Mandel, H. et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat. Genet. 29, 337\u2013341 (2001).","journal-title":"Nat. Genet."},{"key":"101_CR155","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ng2040","volume":"39","author":"A Bourdon","year":"2007","unstructured":"Bourdon, A. et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat. Genet. 39, 776\u2013780 (2007).","journal-title":"Nat. Genet."},{"key":"101_CR156","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/430843","volume":"76","author":"O Elpeleg","year":"2005","unstructured":"Elpeleg, O. et al. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am. J. Hum. Genet. 76, 1081\u20131086 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"101_CR157","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/519222","volume":"81","author":"E Ostergaard","year":"2007","unstructured":"Ostergaard, E. et al. Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am.\u00a0J. Hum. Genet. 81, 383\u2013387 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"101_CR158","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/ng1765","volume":"38","author":"A Spinazzola","year":"2006","unstructured":"Spinazzola, A. et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat. Genet. 38, 570\u2013575 (2006).","journal-title":"Nat. Genet."},{"key":"101_CR159","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cmet.2015.02.008","volume":"21","author":"A Besse","year":"2015","unstructured":"Besse, A. et al. The GABA transaminase, ABAT, is essential for mitochondrial nucleoside metabolism. Cell Metab. 21, 417\u2013427 (2015).","journal-title":"Cell Metab."},{"key":"101_CR160","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1212\/01.wnl.0000335931.54095.0a","volume":"71","author":"JD Stewart","year":"2008","unstructured":"Stewart, J. D. et al. OPA1 in multiple mitochondrial DNA deletion disorders. Neurology 71, 1829\u20131831 (2008).","journal-title":"Neurology"},{"key":"101_CR161","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/brain\/awr323","volume":"135","author":"C Rouzier","year":"2012","unstructured":"Rouzier, C. et al. The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy \u2018plus\u2019 phenotype. Brain 135, 23\u201334 (2012).","journal-title":"Brain"},{"key":"101_CR162","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ajhg.2013.07.017","volume":"93","author":"PE Bonnen","year":"2013","unstructured":"Bonnen, P. E. et al. Mutations in FBXL4 cause mitochondrial encephalopathy and a disorder of mitochondrial DNA maintenance. Am. J. Hum. Genet. 93, 471\u2013481 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"101_CR163","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/ng.544","volume":"42","author":"D Bella Di","year":"2010","unstructured":"Di Bella, D. et al. Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat. Genet. 42, 313\u2013321 (2010).","journal-title":"Nat. Genet."},{"key":"101_CR164","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1212\/01.wnl.0000201185.91110.15","volume":"66","author":"N Elleuch","year":"2006","unstructured":"Elleuch, N. et al. Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia. Neurology 66, 654\u2013659 (2006).","journal-title":"Neurology"},{"key":"101_CR165","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ajhg.2009.04.004","volume":"84","author":"A Fonzo Di","year":"2009","unstructured":"Di Fonzo, A. et al. The mitochondrial disulfide relay system protein GFER is mutated in autosomal-recessive myopathy with cataract and combined respiratory-chain deficiency. Am. J. Hum. Genet. 84, 594\u2013604 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"101_CR166","doi-asserted-by":"crossref","first-page":"18054","DOI":"10.3390\/ijms160818054","volume":"16","author":"N Ahmed","year":"2015","unstructured":"Ahmed, N., Ronchi, D. & Comi, G. P. Genes and pathways involved in adult onset disorders featuring muscle mitochondrial DNA instability. Int. J. Mol. Sci. 16, 18054\u201318076 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"101_CR167","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.1093\/brain\/awm009","volume":"130","author":"K Craig","year":"2007","unstructured":"Craig, K. et al. The A467T and W748S POLG substitutions are a rare cause of adult-onset ataxia in Europe. Brain 130, E69 (2007).","journal-title":"Brain"},{"key":"101_CR168","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.410320610","volume":"32","author":"AR Bicknese","year":"1992","unstructured":"Bicknese, A. R., May, W., Hickey, W. F. & Dodson, W. E. Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity. Ann. Neurol. 32, 767\u2013775 (1992).","journal-title":"Ann. Neurol."},{"key":"101_CR169","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1034\/j.1399-3046.2000.00090.x","volume":"4","author":"A Delarue","year":"2000","unstructured":"Delarue, A. et al. Inappropriate liver transplantation in a child with Alpers\u2013Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure. Pediatr. Transplant. 4, 67\u201371 (2000).","journal-title":"Pediatr. Transplant."},{"key":"101_CR170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1034\/j.1399-3046.2000.00115.x","volume":"4","author":"N Kayihan","year":"2000","unstructured":"Kayihan, N., Nennesmo, I., Ericzon, B. G. & Nemeth, A. Fatal deterioration of neurological disease after orthotopic liver transplantation for valproic acid-induced liver damage. Pediatr. Transplant. 4, 211\u2013214 (2000).","journal-title":"Pediatr. Transplant."},{"key":"101_CR171","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ymgme.2016.04.009","volume":"118","author":"S Parikh","year":"2016","unstructured":"Parikh, S. et al. Solid organ transplantation in primary mitochondrial disease: proceed with caution. Mol. Genet. Metab. 118, 178\u2013184 (2016).","journal-title":"Mol. Genet. Metab."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41582-018-0101-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41582-018-0101-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41582-018-0101-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:10:52Z","timestamp":1684606252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-018-0101-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,19]]},"references-count":171,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["101"],"URL":"https:\/\/doi.org\/10.1038\/s41582-018-0101-0","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,19]]},"assertion":[{"value":"19 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}